PubRank

E A Rachmilewitz

Author PubWeight™ 137.72‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Unstable beta-globin mRNA in mRNA-deficient beta o thalassemia. Cell 1981 3.80
2 A unique natural human IgG antibody with anti-alpha-galactosyl specificity. J Exp Med 1984 3.07
3 Non-specific serum iron in thalassaemia: an abnormal serum iron fraction of potential toxicity. Br J Haematol 1978 2.07
4 The present status of the heterogeneity of fetal hemoglobin in beta-thalassemia: an attempt to unify some observations in thalassemia and related conditions. Ann N Y Acad Sci 1974 1.99
5 Proliferation and maturation of human erythroid progenitors in liquid culture. Blood 1989 1.78
6 The effects of protein conformation on the heme symmetry in high spin ferric heme proteins as studied by electron paramagnetic resonance. J Biol Chem 1971 1.57
7 Adding fresh frozen plasma to rituximab for the treatment of patients with refractory advanced CLL. QJM 2008 1.56
8 Brief report: tumor lysis syndrome following treatment with 2-chlorodeoxyadenosine for refractory chronic lymphocytic leukemia. N Engl J Med 1993 1.51
9 Ovarian tissue banking in patients with Hodgkin's disease: is it safe? Fertil Steril 1998 1.46
10 Demonstration of a natural antigalactosyl IgG antibody on thalassemic red blood cells. Blood 1983 1.41
11 Activated oxygen and haemolysis. Br J Haematol 1975 1.41
12 Studies on the stability of oxyhemoglobin A and its constituent chains and their derivatives. J Biol Chem 1971 1.38
13 Cardiopulmonary assessment in beta-thalassemia major. Chest 1990 1.26
14 Oxidative denaturation of red blood cells in thalassemia. Semin Hematol 1990 1.24
15 Lipid membrane peroxidation in beta-thalassemia major. Blood 1976 1.18
16 Denaturation of the normal and abnormal hemoglobin molecule. Semin Hematol 1974 1.17
17 Role of haemichromes in the formation of inclusion bodies in haemoglobin H disease. Nature 1969 1.12
18 Acute promyelocytic leukaemia with t(15;17) following treatment of Hodgkin's disease--a report of 4 cases. Ann Oncol 1995 1.09
19 Microsatellite instability and p53 mutations in therapy-related leukemia suggest mutator phenotype. Blood 1996 1.08
20 beta 0-Thalassemia complicated by autoimmune hemolytic anemia. Globin synthesis during immunosuppressive therapy. Acta Haematol 1980 1.06
21 Optic atrophy following treatment with cobalt chloride in a patient with pancytopenia and hypercellular marrow. Isr J Med Sci 1972 1.05
22 Essential cryofibrinogenemia. Clinical, pathological and immunological studies. Isr J Med Sci 1970 1.05
23 The natural anti-alpha-galactosyl IgG on human normal senescent red blood cells. Br J Haematol 1986 1.05
24 Gonadotrophin, thyrotrophin and prolactin reserve in beta thalassaemia. Clin Endocrinol (Oxf) 1978 1.04
25 In-vivo platelet activation correlates with red cell anionic phospholipid exposure in patients with beta-thalassaemia major. Br J Haematol 1997 1.02
26 A new polymorphism in the human beta-globin gene useful in antenatal diagnosis. J Clin Invest 1981 1.02
27 Erythropoietin triggers a burst of GATA-1 in normal human erythroid cells differentiating in tissue culture. Nucleic Acids Res 1993 1.00
28 Absence of beta mRNA in beta0-thalassemia in Kurdish Jews. Blood 1978 1.00
29 Erythrocyte membrane skeleton abnormalities in severe beta-thalassemia. Blood 1987 0.99
30 Novel treatment options in the severe beta-globin disorders. Br J Haematol 1995 0.99
31 The demonstration of ferrihemochrome intermediates in heinz body formation following the reduction of oxyhemoglobin A by acetylphenylhydrazone. Biochim Biophys Acta 1975 0.99
32 Blood group phenotypes and hemoglobin S. An anthropologic study in two Israeli Arab communities. Acta Haematol 1976 0.98
33 Superoxide dismutase in red blood cells: method of assay and enzyme content in normal subjects and in patients with beta-thalassemia (major and intermedia). J Lab Clin Med 1976 0.98
34 Mean corpuscular volume of heterozygotes for beta-thalassemia correlates with the severity of mutations. Blood 1992 0.98
35 The two-step liquid culture: a novel procedure for studying maturation of human normal and pathological erythroid precursors. Stem Cells 1993 0.97
36 Quantitative studies of ferritinlike iron in erythrocytes of thalassemia, sickle-cell anemia, and hemoglobin Hammersmith with Mössbauer spectroscopy. Proc Natl Acad Sci U S A 1979 0.96
37 Juvenile leg ulceration in beta-thalassemia major and intermedia. Plast Reconstr Surg 1982 0.96
38 Phosphatidylserine in the outer leaflet of red blood cells from beta-thalassemia patients may explain the chronic hypercoagulable state and thrombotic episodes. Am J Hematol 1993 0.96
39 Blood group phenotypes and the origin of sickle cell hemoglobin in Sicilians. Acta Haematol 1978 0.94
40 Visceral leishmaniasis: a difficult diagnosis and unusual causative agent. J Infect Dis 1991 0.94
41 A chronic hypercoagulable state in patients with beta-thalassaemia major is already present in childhood. Br J Haematol 1999 0.93
42 Two mutations in the beta-globin polyadenylylation signal reveal extended transcripts and new RNA polyadenylylation sites. Proc Natl Acad Sci U S A 1992 0.92
43 Enhanced generation of monocyte tissue factor and increased plasma prothrombin fragment1+2 levels in patients with polycythemia vera: mechanism of activation of blood coagulation. Am J Hematol 1997 0.91
44 Differing erythrocyte membrane skeletal protein defects in alpha and beta thalassemia. J Clin Invest 1989 0.91
45 Nonspecific serum iron in thalassemia: quantitation and chemical reactivity. Am J Hematol 1979 0.91
46 Expression of granulocytic functions by leukemic promyelocytic HL-60 cells: differential induction by dimethylsulfoxide and retinoic acid. Cell Differ 1987 0.90
47 Homozygous beta0- and beta+ - thalassemia in Kurdish Jews and Arabs. Hemoglobin 1977 0.90
48 In vivo platelet activation in beta-thalassemia major reflected by increased platelet-thromboxane urinary metabolites. Blood 1991 0.90
49 Ultrastructural studies in -thalassaemia major. Br J Haematol 1973 0.89
50 Formation of hemichromes from oxidized hemoglobin subunits. Ann N Y Acad Sci 1969 0.89
51 The interaction of hemoglobin O Arab with Hb S and beta+ thalassemia among Israeli Arabs. Hum Genet 1985 0.89
52 Self-renewal and commitment to differentiation of human leukemic promyelocytic cells (HL-60). J Cell Physiol 1982 0.88
53 Cross-sectional and longitudinal study of the pituitary-thyroid axis in patients with thalassaemia major. Clin Endocrinol (Oxf) 1993 0.88
54 Mechanism of desferrioxamine-induced iron excretion in thalassaemia. Br J Haematol 1979 0.88
55 Thromboembolic complications in beta thalassemia major. Acta Haematol 1992 0.87
56 Protective effects of tea polyphenols against oxidative damage to red blood cells. Biochem Pharmacol 1997 0.87
57 Relief of pruritus by cholestyramine in chronic liver disease. Isr J Med Sci 1965 0.87
58 Phagocytosis of nucleated and mature beta thalassaemic red blood cells by mouse macrophages in vitro. Br J Haematol 1979 0.87
59 Left ventricular function in beta-thalassemia and the effect of multiple transfusions. Am Heart J 1978 0.86
60 Genetic and molecular diversity in nondeletion Hb H disease. Proc Natl Acad Sci U S A 1981 0.86
61 Adult and neonatal patterns of human globin gene expression are recapitulated in liquid cultures. Exp Hematol 1992 0.86
62 Cross-linking of red blood cell membrane proteins induced by oxidative stress in beta thalassemia. FEBS Lett 1978 0.86
63 Splenectomy in homozygous beta thalassaemia: a retrospective study of 30 patients. Br J Haematol 1975 0.86
64 Protective effects of rutin against hemoglobin oxidation. Biochem Pharmacol 1994 0.85
65 Growth of human normal erythroid progenitors in liquid culture: a comparison with colony growth in semisolid culture. Int J Cell Cloning 1991 0.85
66 Vitamin E deficiency in beta-thalassemia major: changes in hematological and biochemical parameters after a therapeutic trial with alpha-tocopherol. Am J Clin Nutr 1979 0.85
67 Deferiprone (L1) chelates pathologic iron deposits from membranes of intact thalassemic and sickle red blood cells both in vitro and in vivo. Blood 1995 0.85
68 An electron microscopic study of the nuclear abnormalities in erythroblasts in beta-thalassaemia major. Br J Haematol 1974 0.85
69 Isolation, characterization, and immunoprecipitation studies of immune complexes from membranes of beta-thalassemic erythrocytes. Blood 1992 0.85
70 Dapsone-induced methemoglobinemia and hemolysis in the presence of familial hemoglobinopathy Hasharon and familial methemoglobin reductase deficiency. Isr J Med Sci 1981 0.84
71 Haemichrome formation during the in vitro oxidation of Hb Köln. Nat New Biol 1973 0.84
72 Oxidative damage to human red cells induced by copper and iron complexes in the presence of ascorbate. Biochim Biophys Acta 1989 0.84
73 Sickle cell trait in a white Jewish family presenting as splenic infarction at high altitude. Am J Hematol 1988 0.84
74 Tumour promoters induce macrophage differentiation in human myeloid cells from patients with acute and chronic myelogenous leukaemia. Br J Haematol 1981 0.84
75 Disseminated visceral fusariosis treated with amphotericin B-phospholipid complex. Leuk Lymphoma 1993 0.83
76 Erythropoietin activity in the serum of beta thalassemic patients. Scand J Haematol 1986 0.83
77 Deferoxamine improves left ventricular function in beta-thalassemia. Arch Intern Med 1986 0.83
78 Haemoglobinopathies and red cell membrane function. Baillieres Clin Haematol 1993 0.83
79 Recurrent transient bone marrow hypoplasia associated with pregnancy. Acta Haematol 1993 0.83
80 Beta O-thalassemia intermedia. Blood 1978 0.83
81 Modulation of the maturation of human leukemic promyelocytes (HL-60) to granulocytes or macrophages. Leuk Res 1982 0.83
82 Nonrandom association of free iron with membranes of sickle and beta-thalassemic erythrocytes. Blood 1993 0.83
83 Impaired neutrophil chemotaxis in patients with thalassaemia major. Br J Haematol 1993 0.83
84 Impaired erythrocyte calcium homeostasis in beta-thalassemia. Blood 1984 0.82
85 Studies in cryofibrinogenemia. Acta Haematol 1969 0.82
86 Abnormal low and high density lipoproteins in homozygous beta-thalassaemia. Br J Haematol 1991 0.82
87 The effect of an antiserotonin agent pizotifen on platelet aggregability in migraine patients. J Neurol Neurosurg Psychiatry 1980 0.82
88 Differences in the pathophysiology of hemolysis of alpha- and beta-thalassemic red blood cells. Ann N Y Acad Sci 1990 0.82
89 A therapeutic trial in anemia of pregnancy. Isr J Med Sci 1968 0.82
90 Molecular analysis of beta-thalassemia in Vietnam. Hemoglobin 2000 0.82
91 Successful full-term pregnancy in homozygous beta-thalassemia major: case report and review of the literature. Obstet Gynecol 1989 0.82
92 High incidence of cholelithiasis in older patients with homozygous beta-thalassemia. Acta Haematol 1990 0.82
93 A naturally occurring anti-alpha-galactosyl IgG recognizing senescent human red cells. Prog Clin Biol Res 1985 0.81
94 Pulmonary thromboembolism in thalassemia intermedia patients. Haematologica 1999 0.81
95 Alterations in the red blood cell membrane and the effect of vitamin E on osmotic fragility in beta-thalassemia major. Isr J Med Sci 1976 0.81
96 Effect of extracellular hemin on hemoglobin and ferritin content of erythroleukemia cells. J Cell Physiol 1987 0.81
97 Ultrastructure of the inclusion bodies and nuclear abnormalities in beta-thalassemic erythroblasts. Ann N Y Acad Sci 1974 0.81
98 Calcium transport and ultrastructure of red cells in beta-thalassemia intermedia. Blood 1988 0.80
99 Platelet survival in patients with beta-thalassemia. Am J Hematol 1989 0.80
100 Hemoglobinopathies in Israel. Hemoglobin 1983 0.80
101 Beta-thalassemia: analysis of mRNA precursors of a mutant human globin gene with defective splicing using peripheral blood nucleated red blood cells. Hemoglobin 1986 0.80
102 Bone marrow transplantation in thalassaemia. Bone Marrow Transplant 1986 0.80
103 Intrinsic potential for high fetal hemoglobin production in a Druz family with beta-thalassemia is due to an unlinked genetic determinant. Hum Genet 1990 0.80
104 Inadequate utilization of routine electronic RBC counts to identify beta thalassemia carriers. Am J Public Health 1988 0.80
105 Susceptibility of thalassemic red blood cells to phagocytosis by human macrophages in vitro. Ann N Y Acad Sci 1980 0.79
106 TSH secretion in thalassemia. J Endocrinol Invest 1984 0.79
107 Sporadic alleles, including a novel mutation, characterize beta-thalassemia in Ashkenazi Jews. Hum Mutat 1993 0.79
108 Vitamin E deficiency due to increased consumption in beta-thalassemia and in Gaucher's disease. Ann N Y Acad Sci 1982 0.79
109 Administration of erythropoietin to patients with beta-thalassemia intermedia: a preliminary trial. Blood 1991 0.79
110 Erythrocyte membrane alterations in beta-thalassaemia. Clin Haematol 1985 0.79
111 Ferritin concentration in normal and abnormal erythrocytes measured by immunoradiometric assay with antibodies to heart and spleen ferritin and Mössbauer spectroscopy. Br J Haematol 1981 0.79
112 A two-step liquid culture--a novel culture procedure for studying erythroid cell development. Haematologia (Budap) 1991 0.78
113 Detection of specific beta-globin mutations in Kurdish Jews with beta-thalassemia. Hemoglobin 1988 0.78
114 Aseptic cavernous sinus thrombosis after internal carotid arterial occlusion in polycythaemia vera. J Neurol Neurosurg Psychiatry 1976 0.78
115 Molecular studies of beta-thalassemia in Israel. Mutational analysis and expression studies. Ann N Y Acad Sci 1990 0.78
116 Molecular follow-up of disease progression and interferon therapy in chronic myelocytic leukemia. Blood 1997 0.78
117 Distribution of sialic acids on the red blood cell membrane in beta thalassaemia. Nature 1978 0.78
118 Flow cytofluorometric analysis of the uptake of the fluorescent fatty acid pyrene-dodecanoic acid by human peripheral blood cells. Cytometry 1988 0.78
119 Efficient introduction of plasmid DNA into human hemopoietic cells by encapsidation in simian virus 40 pseudovirions. Proc Natl Acad Sci U S A 1986 0.78
120 "Lysosomal" enzyme activities in red blood cells of normal individuals and patients with homozygous beta-thalassaemia. Clin Chim Acta 1979 0.78
121 Hydroxyl radical generation in beta-thalassemic red blood cells. Free Radic Biol Med 1995 0.78
122 Changes in cell kinetics associated with differentiation of a human promyelocytic cell line (HL60). Cell Tissue Kinet 1982 0.78
123 Generation of procoagulant activity (PCA) by phorbol-esters-induced macrophages derived from a leukemic promyelocytic cell line (HL-60). Blood 1982 0.77
124 The red blood cell membrane in thalassaemia. Br J Haematol 1980 0.77
125 The role of intracellular hemoglobin precipitation, low MCHC, and iron overload on red blood cell membrane peroxidation in thalassemia. Birth Defects Orig Artic Ser 1976 0.77
126 Bone density, mineral content, and cortical index in patients with thalassemia major and the correlation to their bone fractures, blood transfusions, and treatment with desferrioxamine. Calcif Tissue Int 1992 0.77
127 Proliferation and differentiation of erythroid progenitors in liquid culture: analysis of progenitors derived from patients with polycythemia vera. Am J Hematol 1990 0.77
128 Hemichromes in single inclusion bodies in red cells of beta thalassemia. Blood 1972 0.77
129 Stimulation of proliferation of human myeloid leukemia cells in culture: applications for cytogenetic analysis. Blood 1986 0.77
130 Generation of procoagulant activity (PCA) by macrophage-like cells derived from acute and chronic myeloid leukaemia cells in response to phorbol esters. Scand J Haematol 1983 0.77
131 Efficient introduction and transient expression of exogenous genes in human hemopoietic cells. Ann N Y Acad Sci 1987 0.77
132 Cell-mediated immunity in idiopathic autoimmune haemolytic disease. Clin Exp Immunol 1975 0.77
133 Selective photosensitization of human leukemic cells by a pyrene-containing fatty acid. Exp Hematol 1990 0.76
134 ABL1 methylation in Ph-positive ALL is exclusively associated with the P210 form of BCR-ABL. Leukemia 2001 0.76
135 Selective toxicity towards myelodysplastic hematopoietic progenitors - another rationale for iron chelation in MDS. Leuk Res 2012 0.76
136 Stimulation of erythroid progenitors by high concentrations of erythropoietin results in normoblasts arrested in G2 phase of the cell cycle. Exp Hematol 1993 0.76
137 In vitro generation of procoagulant activity by leukemic promyelocytes in response to cytotoxic drugs. Am J Hematol 1985 0.76
138 [Thalassemia minor and iron deficiency anemia among Israeli soldiers]. Harefuah 1986 0.76
139 Paravertebral extramedullary hematopoiesis associated with improvement of anemia in congenital dyserythropoietic anemia type II. Am J Hematol 1986 0.76
140 Globin synthesis in severe and intermediate homozygous beta thalassemia in Israel. Ann N Y Acad Sci 1980 0.76
141 Spontaneous commitment of murine erythroleukemic cells to terminal differentiation. Cancer Res 1983 0.76
142 The erythrocyte membranes in beta-thalassemia. Lower sialic acid levels in glycophorin. Biochim Biophys Acta 1980 0.76
143 Induction of differentiation of myeloid leukemic cells by busulphan: in vivo and in vitro observations. Leuk Lymphoma 1993 0.76
144 Endometrial glandular haemosiderosis in homozygous beta-thalassaemia. Eur J Obstet Gynecol Reprod Biol 1989 0.76
145 Hemoglobin switching in humans is accompanied by changes in the ratio of the transcription factors, GATA-1 and SP1. Mol Med 1995 0.75
146 Prenatal diagnosis of heterozygous beta-thalassemia. Isr J Med Sci 1976 0.75
147 Absence of functional beta-globin messenger RNA in Kurdish Jews with beta0-thalassemia. Isr J Med Sci 1978 0.75
148 Bone marrow transplantation in beta-thalassemia major. The Israeli experience. Hemoglobin 1988 0.75
149 Alterations in membrane protein and phosphorylation pattern in beta-thalassemic red blood cells. Ann N Y Acad Sci 1985 0.75
150 Improved method for diagnosis of polycythemia vera based on flow cytometric analysis of autonomous growth of erythroid precursors in liquid culture. Am J Hematol 1997 0.75
151 Induction of differentiation in human myeloid leukemic cells by T-2 toxin and other trichothecenes. Toxicol Appl Pharmacol 1987 0.75
152 Photosensitization of human bladder carcinoma cells by pyrene-dodecanoic acid: quantitative analysis of the cytotoxicity. Res Exp Med (Berl) 1992 0.75
153 Bone marrow transplantation with T-cell depleted allografts for the treatment of severe beta thalassemia major. Prog Clin Biol Res 1989 0.75
154 Evaluating the impact of age and disease on survival of chronic lymphocytic leukaemia patients by a new method. Int J Clin Pract 2009 0.75
155 Studies of left-ventricular function in anemia due to beta-thalassemia. Isr J Med Sci 1982 0.75
156 A noninvasive method for the evaluation of tissue iron deposition in beta-thalassemia major. J Lab Clin Med 1978 0.75
157 Separation of alpha- and beta-chains of hemoglobin A by acetylphenylhydrazine. Biochim Biophys Acta 1974 0.75
158 Analysis of cellular heterogeneity in the response of human leukemic cells to photosensitization induced by pyrene-containing fatty acid. Leuk Res 1989 0.75
159 Pancytopenia with hypercellular hemopoietic tissue. Isr J Med Sci 1969 0.75
160 Flow cytometric analysis of the ploidy of normoblasts in the peripheral blood of patients with beta-thalassemia. Am J Hematol 1993 0.75
161 Noninvasive analysis of skin iron and zinc levels in beta-thalassemia major and intermedia. J Lab Clin Med 1985 0.75
162 Acute promyelocytic leukemia in childhood. Report of a case with a review of the literature. Acta Haematol 1979 0.75
163 Globin synthesis in bone marrow cells of patients with sickle cell anemia and beta O-thalassemia: contamination of the beta-chain with non-globin proteins. Hemoglobin 1979 0.75
164 Results of therapy in adult acute nonlymphoblastic leukemia: experience in Jerusalem, Israel, during 1975-1982. Acta Haematol 1985 0.75
165 Juvenile myeloid leukemia with fetal erythropoiesis. Cancer 1972 0.75
166 The effect of central nervous system stimulation on erythropoiesis in rats with chronically implanted electrodes. J Lab Clin Med 1966 0.75
167 Slow rate of haemichrome formation from oxidized haemoglobin Bart's (4 ): a possible explanation for the unequal quantities of haemoglobins H ( 4 ) and Bart's in alpha-thalassaemia. Br J Haematol 1972 0.75
168 Aplastic anemia after prolonged ingestion of indomethacin. Acta Haematol 1982 0.75
169 Reduced frequency of iron deficiency anaemia in sickle cell trait. Scand J Haematol 1982 0.75
170 Hydrolase activities in normoblasts of beta-thalassemic patients. Isr J Med Sci 1978 0.75
171 Isolation and characterization of HL-60 cell variants with different potentials for spontaneous differentiation. Leukemia 1991 0.75
172 [The mechanism of response of the activated macrophage]. Harefuah 1981 0.75
173 Establishment of a fetoscopy and fetal blood sampling program in Israel. Isr J Med Sci 1981 0.75
174 Hypercalcemia complicating a megakaryoblastic crisis of chronic myelocytic leukemia. Isr J Med Sci 1988 0.75
175 Intracerebral tumor and diffuse central nervous system infiltration complicating acute myelogenous leukemia. Cancer 1979 0.75
176 Circulating erythroid progenitors in patients with 'spent' polycythaemia vera and myelofibrosis with myeloid metaplasia. Br J Haematol 1982 0.75
177 Acute promyelocytic leukaemia: a report of five cases with a comment on the diagnostic significance of serum vitamin B 12 determination. Br J Haematol 1972 0.75
178 Heterogeneity of fetal hemoglobin among Israel families with beta-thalassemia. Isr J Med Sci 1974 0.75
179 Changes in cellular ferritin content during myeloid differentiation of human leukemic cell lines. Am J Hematol 1985 0.75
180 [Central nervous system involvement in acute myelogenous leukemia]. Harefuah 1979 0.75
181 Defibrination syndrome followed by hypercoagulable state. Thromb Diath Haemorrh 1967 0.75
182 Hairy cell leukemia: results of 2-chlorodeoxyadenosine therapy in Jerusalem. Leuk Lymphoma 1994 0.75
183 Alterations in structure, function, and Ca++ content of thalassemic red blood cells. Biomed Biochim Acta 1983 0.75
184 Disseminated intravascular coagulation in two patients with histiocytic medullary reticulosis. Am J Clin Pathol 1984 0.75
185 Priapism in a non-black with sickle cell anemia associated with alpha-thalassemia. Am J Hematol 1981 0.75
186 Splenectomy, iron overload and liver cirrhosis in beta-thalassemia major. Acta Haematol 1976 0.75
187 The inhibitory effect of vitamin E on desferrioxamine-induced iron excretion in rats. Proc Soc Exp Biol Med 1976 0.75
188 Intermediate hemichrome formation after oxidation of three unstable hemoglobins (Freiburg, Riverdale-Bronx and Köln). Hamatol Bluttransfus 1972 0.75
189 Left ventricular filling and emptying patterns in anemia due to beta thalassemia. A computer-assisted echocardiographic study. Cardiology 1982 0.75
190 Growth and sexual development before and after sex steroid therapy in patients with thalassemia major. Arch Intern Med 1984 0.75
191 Effect of central nervous system stimulation on erythropoiesis in the rat. Isr J Med Sci 1965 0.75
192 A patient of German descent with (delta beta)0-thalassemia carrying the Sicilian type deletion of the delta and beta globin genes. Hemoglobin 1988 0.75
193 Serum antibodies against desipramine as a possible cause for thrombocytopenia. Blood 1968 0.75
194 Iron incorporation into ferritin and hemoglobin during differentiation of murine erythroleukemia cells. Blood 1981 0.75
195 Myelofibrosis, osteolytic bone lesions and hypercalcemia in chronic myeloid leukemia. Acta Haematol 1973 0.75
196 [Blood transfusion in thalassemia--the Jerusalem experience]. Harefuah 1985 0.75
197 Primaquine-induced superoxide production by beta-thalassemic red blood cells. Biochim Biophys Acta 1992 0.75
198 Iron chelation in thalassemia: mechanism of desferrioxamine action. Isr J Med Sci 1978 0.75
199 Pathologic changes of red blood cell membranes in thalassemia. Morphologic, metabolic, and biochemical changes in thalassemic RBC membranes. Birth Defects Orig Artic Ser 1982 0.75
200 Differentiation of human myeloid leukemic cells by phorbol esters: correlation with tumor promotion. Int J Cancer 1984 0.75
201 Iron storage in ferritin following intracellular hemoglobin denaturation in erythroleukemic cells. Blood 1983 0.75
202 Characterization of the normoblast population in beta-thalassaemic blood by rapid-flow cytofluorometry. Scand J Haematol 1978 0.75